background image

Paid Clinical Trials Kansas

Discover 852 paid clinical trials in Kansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Little Rock AR, Tyler TX, McKinney TX, Frisco TXshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Ridgeland MS, Flowood MS, Dallas TX, Lewisville TXshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

Recruiting
PHASE1

Sponsor:

Vanda Pharmaceuticals

Location:

Fairway KS, Lafayette IN, Washington DC, Hackensack NJshow 1 more

Code:

NCT03838926

Conditions

Relapsed or Refractory Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Trichostatin A

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Memphis TN, Cordova TN, Ridgeland MS, Bolivar MOshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Little Rock AR, Jonesboro AR, Southhaven MS, Memphis TNshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting
PHASE2

Sponsor:

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Location:

Little Rock AR, Saint Louis MO, Dallas TX, Nashville TNshow 34 more

Code:

NCT06297226

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Arlocabtagene Autoleucel (BMS-986393)

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting
PHASE3

Sponsor:

GB002, Inc.

Location:

Plano TX, Saint Louis MO, Columbia MO, Dallas TXshow 51 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

Early Versus Delayed Urinary Catheter Removal After Minimally Invasive Lumbar Spine Surgery

Recruiting

Sponsor:

University of Kansas Medical Center

Location:

Kansas City KS

Code:

NCT05359926

Conditions

Foley Catheterization

Ambulation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Experimental

Active comparator

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Recruiting
PHASE3

Sponsor:

GT Medical Technologies, Inc.

Location:

Little Rock AR, Saint Louis MO, Columbia MO, Dallas TXshow 27 more

Code:

NCT04365374

Conditions

Brain Metastases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)

Stereotactic Radiation Therapy

Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Recruiting
PHASE1
PHASE2

Sponsor:

Genmab

Location:

Tyler TX, Dallas TX, Oklahoma City OK, Nashville TNshow 26 more

Code:

NCT05579366

Conditions

Platinum-Resistant Ovarian Cancer

Platinum Sensitive Ovarian Cancer (PSOC)

High Grade Epithelial Ovarian Cancer

High Grade Serous Ovarian Cancer

Primary Peritoneal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rina-S

Carboplatin

Bevacizumab

Pembrolizumab

Popular cities in Kansas

With a well-established healthcare network and renowned medical research institutions, Kansas has emerged as a significant hub for a wide range of clinical trials. Leading institutions such as The University of Kansas Medical Center, Wesley Medical Center, and Children's Mercy Kansas City are at the forefront of groundbreaking studies.

These centers are recognized for their contributions to innovative medical research, helping to advance treatments in fields such as oncology, cardiology, and pediatrics.

Why choose Kansas for clinical trials?

Common conditions studied in Kansas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Kansas